✦ LIBER ✦

Receptor radionuclide therapy with90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

✍ Scribed by Lisa Bodei; Marta Cremonesi; Chiara Grana; Paola Rocca; Mirco Bartolomei; Marco Chinol; Giovanni Paganelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival and Response After Peptide Rece

✍ Roelf Valkema; Stanislas Pauwels; Larry K. Kvols; Raffaella Barone; Francois Jam 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Exceptional Results in Neuroendocrine-Me

✍ C. Waldherr; A. Haldemann; H.R. Maecke; A. Crazzolara; J. Mueller-Brand 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Receptor-mediated radiotherapy with90Y-D

✍ Paganelli, Giovanni; Zoboli, Stefania; Cremonesi, Marta; Bodei, Lisa; Ferrari, M 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 193 KB

Peptide receptor radionuclide therapy wi

✍ Vinjamuri, S; Gilbert, T M; Banks, M; McKane, G; Maltby, P; Poston, G; Weissman, 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 721 KB

Peptide receptor radionuclide therapy wi

✍ Mirco Bartolomei; Lisa Bodei; Concetta De Cicco; Chiara Maria Grana; Marta Cremo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 273 KB

90Y–DOTA–D-Phe1–Try3– octreotide in ther

✍ G. Paganelli; L. Bodei; D. Handkiewicz Junak; P. Rocca; S. Papi; M. Lopera Sierr 📂 Article 📅 2002 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB